Table 3.
Characteristics of patients with and without Holter monitoring
| Holter (n = 15) | No Holter (n = 15) | p | |
|---|---|---|---|
| Age (y) | 47 ± 14 | 53 ± 19 | 0.34 |
| Male, n (%) | 8 (53%) | 10 (67%) | 0.71 |
| Weight (kg) | 74 ± 11 | 70 ± 13 | 0.41 |
| Height (cm) | 176 ± 7 | 178 ± 13 | 0.45 |
| LVEDV (ml) | 191 ± 45 | 193 ± 67 | 0.93 |
| LVEDVI (ml/m2) | 102 ± 25 | 103 ± 34 | 0.92 |
| LVESV (ml) | 85 ± 23 | 83 ± 39 | 0.92 |
| LVEF (%) | 55 ± 8 | 58 ± 9 | 0.33 |
| LV mass index (g/m2) | 65 ± 10 | 66 ± 20 | 0.83 |
| MAD length (mm) | 9.6 [7.6–14.6] | 9.1 [6.3–11.4] | 0.30 |
| Presence of LGE, n (%) | 8 (53%) | 6 (40%) | 0.72 |
| N of positive segments | 3 [2.5–4] | 3.5 [3–4] | 0.59 |
| Basal slice pre-Gd T1 (ms)a | 1109 ± 49 | 1073 ± 66 | 0.11 |
| Basal slice ECVsyn (%)a | 33 ± 5 | 30 ± 3 | 0.03 |
Statistically significant correlation is given in bold
ECVsyn synthetic extracellular volume, LV left ventricle, LVEDV left ventricle end-diastolic volume, LVEDVI left ventricle end-diastolic volume index, LVEF left ventricle ejection fraction; LGE late gadolinium enhancement, Gd gadolinium, MAD mitral annular disjunction
aMean value of inferior and inferolateral segments